| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1528-1157.1999.TB02012.X |
| P698 | PubMed publication ID | 10528936 |
| P2093 | author name string | A R Jacobs | |
| C L Harden | |||
| L Ravdin | |||
| M C Pulver | |||
| P433 | issue | 10 | |
| P304 | page(s) | 1402-1407 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | The effect of menopause and perimenopause on the course of epilepsy | |
| P478 | volume | 40 |
| Q35235276 | Age-dependent sex difference of the incidence and mortality of status epilepticus: a twelve year nationwide population-based cohort study in Taiwan |
| Q35817278 | Bone disease in epilepsy |
| Q93122875 | Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy |
| Q91782387 | Effect of Time Management Training on Anxiety, Depression, and Sleep Quality |
| Q81870506 | Effects of Treatment on Endocrine Function in Patients with Epilepsy |
| Q38235605 | Epilepsy and menopause: potential implications for pharmacotherapy |
| Q55402927 | Estrogen Protects Neurotransmission Transcriptome During Status Epilepticus. |
| Q37399572 | Female issues in epilepsy: a critical review |
| Q34015787 | Females, their estrogens, and seizures. |
| Q37419974 | Gender-specific psychosocial impact of living with epilepsy |
| Q36307451 | High risk of developing subsequent epilepsy in patients with sleep-disordered breathing |
| Q33638313 | Hormonal aspects of epilepsy |
| Q37301514 | Hormonal influences on seizures: basic neurobiology |
| Q37859639 | Hormonal therapy for epilepsy |
| Q24644548 | Hormone replacement therapy: will it affect seizure control and AED levels? |
| Q34712282 | Influence of sex hormones on brain excitability and epilepsy |
| Q37301584 | Issues for mature women with epilepsy |
| Q24680158 | Management of epilepsy in women |
| Q35550766 | Medical comorbidities in the treatment of epilepsy |
| Q35803765 | More is not better: hormones for menopausal women with epilepsy? |
| Q36173874 | Neuroendocrine aspects of catamenial epilepsy |
| Q37055791 | Neuroendocrine considerations in the treatment of men and women with epilepsy |
| Q28388388 | Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion |
| Q27026373 | Neurosteroids and their role in sex-specific epilepsies |
| Q36179368 | Sex and hormonal influences on seizures and epilepsy |
| Q36293915 | Sexuality in women with epilepsy |
| Q36976844 | Tamoxifen mimics the effects of endogenous ovarian hormones on repeated seizures induced by pentylenetetrazole in rats |
| Q35537866 | The Association Between Antiepileptic Drugs and Bone Disease |
| Q36094647 | The current state of postmenopausal hormone therapy: update for neurologists and epileptologists |
| Q24670092 | The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female |
| Q37227965 | The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy |
| Q24561815 | The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment |
| Q34254779 | Treatment issues for women with epilepsy |
| Q30245064 | Women with epilepsy: clinically relevant issues |
| Q36896245 | Women with epilepsy: hormonal issues from menarche through menopause. |
Search more.